Human immunodefeciency virus associated cryptococcal meningitis at a tertiary care centre: diagnostic tools and

Rashmi Munivenkataswamy1, Anjana Gopi, Shaik Mohammed Usman

  • 1Consultant, Department of Microbiologist, Gokula Metro Polis Diagnostics , Bangalore, India .

Abstract

Insights

Cryptococcal meningitis affects 18.2% of HIV-positive individuals. Early microbiological diagnosis and antifungal susceptibility testing are crucial for managing this opportunistic infection in HIV patients.

Area of Science:

  • Infectious Diseases
  • Neuroscience
  • Mycology

Background:

  • Cryptococcal meningitis is a major cause of illness and death in HIV-positive individuals, often presenting as an opportunistic neuroinfection.
  • Early diagnosis is critical for successful treatment, as symptoms can mimic other forms of meningitis.

Purpose of the Study:

  • To determine the incidence of Cryptococcal meningitis in HIV-positive individuals.
  • To evaluate microbiological diagnostic methods for Cryptococcal meningitis.
  • To assess antifungal resistance in Cryptococcal isolates from this population.

Main Methods:

  • Analyzed 66 cerebrospinal fluid (CSF) samples from suspected meningoencephalitis cases.
  • Employed microscopy, culture, melanin production, urea hydrolysis, nitrate assimilation, and latex agglutination for Cryptococcus identification.
  • Determined Minimum Inhibitory Concentrations (MICs) for Amphotericin B and Fluconazole.

Main Results:

  • The incidence of Cryptococcal meningitis was 18.2% (12/66).
  • Cryptococcal antigen detection was positive in all 12 cases; microscopy and culture were positive in 9 and 10 cases, respectively.
  • All isolates were susceptible to Amphotericin B, and 90% were susceptible to Fluconazole; CD4 counts ranged from 22-138 cells/μl.

Conclusions:

  • The high incidence underscores the need for prompt and accurate microbiological diagnosis of Cryptococcal meningitis in HIV-positive patients.
  • Antifungal susceptibility testing should be encouraged due to rising concerns about drug resistance.